In a recent discussion among the panelists of Barron’s Roundtable, 23andMe, the well-known genetics testing company, faced considerable scrutiny amid significant operational changes. The company announced on Monday that it would cut its workforce by 40%, which translates to more than 200 employees. This decision comes in the wake of an urgent need to restructure...
Subscribe to Updates
Get the latest news and updates directly to your inbox.
© 2025 Arcalis News. All Rights Reserved.